Amniotic fluid glucose: a maternal, fetal, and neonatal correlation

Area of Science:

• Obstetrics and Gynecology
• Neonatal Medicine
• Endocrinology

Background:

• Amniotic fluid glucose levels are known to be elevated in patients with diabetes mellitus.
• The clinical significance of increased amniotic fluid glucose remains unclear.

Purpose of the Study:

• To investigate the correlation between amniotic fluid glucose levels and neonatal outcomes.
• To explore the significance of elevated amniotic fluid glucose in patients with abnormal glucose metabolism.

Main Methods:

• Analysis of amniotic fluid glucose levels in 53 samples from 41 patients.
• Correlation analysis between amniotic fluid glucose concentrations and neonatal hypoglycemia.
• Evaluation of amniotic fluid glucose in patients with recurrent glycosuria.

Main Results:

• A high correlation was observed between amniotic fluid glucose levels ≥30 mg/dL and neonatal hypoglycemia.
• Elevated amniotic fluid glucose was also found in patients with recurrent glycosuria as the sole indicator of abnormal glucose metabolism.

Conclusions:

• Amniotic fluid glucose levels ≥30 mg/dL are a significant indicator of potential neonatal hypoglycemia.
• Elevated amniotic fluid glucose may signal underlying glucose metabolism abnormalities, even with recurrent glycosuria.